Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Mahner

Showing results (441-450 of 455) with videos related to

Pageof 46
Sort By:
Annals of Surgical Oncology|November 30, 2016
Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 StudyRüdiger Klapdor, Peter Hillemanns, Linn Wölber, et al.
Journal of Gynecologic Oncology|October 25, 2024
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trialJanice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study GroupAndreas du Bois, Nina Ewald-Riegler, Nikolaus de Gregorio, et al.
The New England Journal of Medicine|October 9, 2016
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian CancerMansoor R Mirza, Bradley J Monk, Jørn Herrstedt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2022
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III TrialJacobus Pfisterer, Florence Joly, Gunnar Kristensen, et al.
Archives of Gynecology and Obstetrics|October 31, 2018
What is the evidence for lymphadenectomy in presumed early ovarian cancer?Barbara Schmalfeldt, Christine Brambs, Alexander Burges, et al.
Geburtshilfe Und Frauenheilkunde|December 9, 2020
Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense?Linn Woelber, Mareike Bommert, Katharina Prieske, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 25, 2026
Highlights from the 27th European Congress on Gynecological Oncology in Copenhagen: interview compilation of the ENYGO-IJGC editorial fellowsAndrej Cokan, Martina Aida Angeles, Houssein El Hajj, et al.
The Lancet. Oncology|July 28, 2022
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroupIgnace Vergote, Antonio Gonzalez-Martin, Domenica Lorusso, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2016
Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter studyLinn Woelber, Lis-Femke Griebel, Christine Eulenburg, et al.
Pageof 46

Showing results (441-450 of 455) with videos related to

Sort By:
Pageof 46
Annals of Surgical Oncology|November 30, 2016
Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 StudyRüdiger Klapdor, Peter Hillemanns, Linn Wölber, et al.
Journal of Gynecologic Oncology|October 25, 2024
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trialJanice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study GroupAndreas du Bois, Nina Ewald-Riegler, Nikolaus de Gregorio, et al.
The New England Journal of Medicine|October 9, 2016
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian CancerMansoor R Mirza, Bradley J Monk, Jørn Herrstedt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2022
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III TrialJacobus Pfisterer, Florence Joly, Gunnar Kristensen, et al.
Archives of Gynecology and Obstetrics|October 31, 2018
What is the evidence for lymphadenectomy in presumed early ovarian cancer?Barbara Schmalfeldt, Christine Brambs, Alexander Burges, et al.
Geburtshilfe Und Frauenheilkunde|December 9, 2020
Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense?Linn Woelber, Mareike Bommert, Katharina Prieske, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 25, 2026
Highlights from the 27th European Congress on Gynecological Oncology in Copenhagen: interview compilation of the ENYGO-IJGC editorial fellowsAndrej Cokan, Martina Aida Angeles, Houssein El Hajj, et al.
The Lancet. Oncology|July 28, 2022
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroupIgnace Vergote, Antonio Gonzalez-Martin, Domenica Lorusso, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2016
Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter studyLinn Woelber, Lis-Femke Griebel, Christine Eulenburg, et al.
Pageof 46